Back
American Express Co. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
66
AXP
American Express Co.
Last Price:
$362.37
Seasonality Move:
4.73%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.58
Seasonality Move:
40.49%
Buy
66
American Express Co. (AXP)
is a Buy
Is American Express Co. a Buy, Sell or Hold?
-
The current American Express Co. [AXP] share price is $362.28. The Score for AXP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXP Stock Price Chart
What is American Express Co.'s stock price today?
-
The American Express Co. share price today is $362.28The current trend is moderately bullish and AXP is experiencing selling pressure, which indicates risk of future bearish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
AXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.95 | Buy |
| Relative Strength Index (14 RSI): | 53.38 | Buy |
| Chaikin Money Flow: | -1704288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (351.52 - 369.98) | Buy |
| Bollinger Bands (100): | (310.95 - 356.63) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 249389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.15 - 56.87) | Buy |
| Bollinger Bands (100): | (20.01 - 44.73) | Buy |
AXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 365.27 | Sell |
| 20-day SMA: | 359.83 | Buy |
| 50-day SMA: | 350.66 | Buy |
| 200-day SMA: | 309.18 | Buy |
| 8-day EMA: | 364.41 | Sell |
| 20-day EMA: | 360.66 | Buy |
| 50-day EMA: | 351.69 | Buy |
| 200-day EMA: | 318.86 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.55 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 42.23 | Buy |
| 200-day SMA: | 23.8 | Buy |
| 8-day EMA: | 60.08 | Buy |
| 20-day EMA: | 52.14 | Buy |
| 50-day EMA: | 43.49 | Buy |
| 200-day EMA: | 29.21 | Buy |
American Express Co. Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $1.95 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
American Express Co. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||